Skip to main content
TipRanks
Go Ultimate75% OFF

Mark Beaudet Insider Profile

4 Followers

Mark Beaudet, Director at Cipher Pharmaceuticals, holds 99.46K shares in Cipher Pharmaceuticals (Ticker: CPHRF).

Mark Beaudet's Trading History

CPHRF
Cipher Pharmaceuticals
Apr 19, 2019DirectorUninformative Sell―$988.63K
CPHRF
Insider Shares: 99.46K (37.07%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Apr 19, 2019Uninformative BuyC$4.95K4,538C$1.09――
Apr 19, 2019Uninformative SellC$0.001,500C$0.00――
Mar 21, 2019Uninformative BuyC$5.04K3,231C$1.56――
Feb 21, 2019Uninformative BuyC$5.05K3,139C$1.61――
Jan 18, 2019Uninformative BuyC$5.01K3,038C$1.65――

You May Also Like

Mark Beaudet insider profile FAQ

What is the percentage of profitable transactions made by Mark Beaudet?
The percentage of profitable transactions made by Mark Beaudet is 0%.
What is the average return per transaction made by Mark Beaudet?
The average return per transaction made by Mark Beaudet is -35.60%.
What stocks does Mark Beaudet hold?
Mark Beaudet holds: CPHRF stocks.
What was Mark Beaudet's most profitable transaction?
Mark Beaudet’s most profitable transaction was an Informative Buy of CPHRF stock on August 17, 2016. The return on the trade was -12.50%.
What is Mark Beaudet's role in Cipher Pharmaceuticals?
Mark Beaudet's role in Cipher Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.